Panel Presentation: Molecular Diagnostic Approaches to Accelerate and Improve STI Diagnosis & Research

Prompt and early diagnosis of sexually transmitted infections (STIs) is important to enable appropriate treatment and help prevent further transmission. Clinical testing labs require STI testing solutions that help provide confidence, fast turnaround time, and accurate results. In this webinar our speakers will discuss the importance of clinical STI testing and present the TaqPath Menu | GeneProof STI portfolio which supports sexual health testing with CE-marked sexually transmitted infection (STI) assays, designed to provide accurate, reliable results with excellent sensitivity and specificity across a wide variety of bacteria (such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium), parasites (such as Trichomonas vaginalis), or viruses (such as human papillomavirus (HPV) or Herpes simplex virus (HSV-1/2)).

Learning Objectives:

1. Explain the importance STI testing

2. Update on main pathogens causing STI

3. Assess the approved workflow of 11 molecular diagnostic tests

4. Learn about the TaqPath™ Menu | GeneProof™ STI portfolio

5. Explore what's coming next from TaqPath™ Menu | GeneProof